Dr. Danny Issa, MD

Dr. Issa practices at UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health.

Dr. Issa's NPI, 1750631396, was assigned on September 11, 2012. Dr. Issa graduated from Damascus University Faculty of Medicine in 2011. Dr. Issa's California license number on file is A163853.

Dr. Issa's primary practice is UCLA Santa Monica Medical Center, at 1250 16th Street, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 319-4000.

Dr. Issa's primary practice is UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health. Dr. Issa is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Issa to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Issa practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Issa's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Issa is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Issa's licenses on file in 4 states: California, New York, Virginia and Ohio.

Dmand AI lists acid reflux, acute gallbladder or bile duct inflammation, acute gastroduodenitis, colonoscopy, gastroduodenitis, gastrointestinal bleeding, hemorrhoids and intestinal diverticulosis among the conditions Dr. Issa treats.

CMS data shows 712 Medicare services from Dr. Issa across 16 procedure codes in 2024, for 423 Medicare patients. Medicare paid $87,139 for them.

CMS counts 423 Medicare patients who saw Dr. Issa in 2024. The largest group is 65 to 74, with 207 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Issa's median patient age at 64, with 54% women.

In 2024, Dr. Issa wrote 493 Medicare Part D claims for 177 patients. 90% of them were for generic drugs. CMS names the drug for 401 of them, across 11 drugs with 11 or more claims each, at $63,074 in total drug cost. In 2023, CMS named 355 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Issa for performance year 2024, reported as part of a group. Dr. Issa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Issa as offering telehealth. CMS counts 349 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Issa, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 39 papers to Dr. Issa, published from 2013 to 2025. 2019 was the busiest year, with 8. The most frequent topics are Non-alcoholic Fatty Liver Disease, Liver Cirrhosis and Cholangiopancreatography, Endoscopic Retrograde. Dr. Issa has published most often in Endoscopy. Dr. Issa's most frequent co-authors are Reem Z. Sharaiha, MD, MS, Kartik Sampath, MD and David Leslie Carr-Locke, MD.

CMS Open Payments shows 240 general payments to Dr. Issa from 17 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Eli Lilly and Company paid the most, $140,121.

Dmand AI lists 5 awards for Dr. Issa, most recently HealthCare Hero Recognition in 2023.

Dr. Issa graduated from Damascus University Faculty of Medicine in 2011. Dr. Issa is a member of ACG, ACP, AGA, AMA and ASGE.

Dr. Issa is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.